AUC passes, Cmax fails: biopharmaceutical difference [PK / PD]

posted by Helmut Homepage – Vienna, Austria, 2021-03-23 12:03 (808 d 04:58 ago) – Posting: # 22292
Views: 1,138

Merhaba akif,

❝ I want to know that why while auc with in spect Cmax out of it? its means that test has higher dissolution rate everytime, …


Only if your drug is in BCS class I or – under certain conditions – in class III, dissolution plays a major rule. If in class II/IV, dissolution is not predictive. There are a manifold of reasons with the absorption rate differs between products. Even if excipients and their amount are identical, differences in the manufacturing process may explain the different absorption.

❝ … or can cause another thing such as CRO, …


No.

❝ … design of study, …


Only if you have problems with a “first point Cmax”.

❝ … bioanalytical method?


No.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,627 posts in 4,743 threads, 1,613 registered users;
25 visitors (0 registered, 25 guests [including 18 identified bots]).
Forum time: 18:02 CEST (Europe/Vienna)

Facts are meaningless. You could use facts to prove
anything that’s even remotely true!    Homer Simpson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5